HemaSphere (Aug 2023)
P1292: BASILIXIMAB MAY BE THE POTENTIAL SOLUTION FOR SEVERE LIVER CHRONIC GRAFT-VERSUS-HOST DISEASE: A PROSPECTIVE PILOT STUDY
- Dao-Xing Deng,
- Meng-Zhu Shen,
- Xiao-Hui Zhang,
- Lanping Xu,
- Yu Wang,
- Chen-Hua Yan,
- Yu-Hong Chen,
- Huan Chen,
- Wei Han,
- Feng-Rong Wang,
- Jing-Zhi Wang,
- Xiao-Jun Huang,
- Xiao-Dong Mo
Affiliations
- Dao-Xing Deng
- 1 Peking University People’s Hospital, Peking University Institute of Hematology, Beijing, China
- Meng-Zhu Shen
- 1 Peking University People’s Hospital, Peking University Institute of Hematology, Beijing, China
- Xiao-Hui Zhang
- 1 Peking University People’s Hospital, Peking University Institute of Hematology, Beijing, China
- Lanping Xu
- 1 Peking University People’s Hospital, Peking University Institute of Hematology, Beijing, China
- Yu Wang
- 1 Peking University People’s Hospital, Peking University Institute of Hematology, Beijing, China
- Chen-Hua Yan
- 1 Peking University People’s Hospital, Peking University Institute of Hematology, Beijing, China
- Yu-Hong Chen
- 1 Peking University People’s Hospital, Peking University Institute of Hematology, Beijing, China
- Huan Chen
- 1 Peking University People’s Hospital, Peking University Institute of Hematology, Beijing, China
- Wei Han
- 1 Peking University People’s Hospital, Peking University Institute of Hematology, Beijing, China
- Feng-Rong Wang
- 1 Peking University People’s Hospital, Peking University Institute of Hematology, Beijing, China
- Jing-Zhi Wang
- 1 Peking University People’s Hospital, Peking University Institute of Hematology, Beijing, China
- Xiao-Jun Huang
- 1 Peking University People’s Hospital, Peking University Institute of Hematology, Beijing, China
- Xiao-Dong Mo
- 1 Peking University People’s Hospital, Peking University Institute of Hematology, Beijing, China
- DOI
- https://doi.org/10.1097/01.HS9.0000972056.91461.24
- Journal volume & issue
-
Vol. 7
p. e9146124
Abstract
No abstracts available.